Imbio Lung Density Analysis
Payments companies reported to CMS as associated with Imbio Lung Density Analysis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Imbio Lung Density Analysis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Imbio Lung Density Analysis
These are the largest totals companies reported as associated with Imbio Lung Density Analysis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Terry Robinson | Palo Alto, CA | Pediatric Pulmonology | $20,000.00 |
| Ritu Gill | New York, NY | Diagnostic Radiology | $13,500.00 |
| Ruchi Yadav | Cleveland, OH | Diagnostic Radiology | $13,500.00 |
| Beverley Newman | Palo Alto, CA | Pediatric Radiology | $5,000.00 |
| Anil Attili | Ann Arbor, MI | Diagnostic Radiology | $3,920.00 |
| Sadia Benzaquen | Cincinnati, OH | Critical Care Medicine (Internal Medicine) | $300.00 |
| Richard Thomas | Burlington, MA | Diagnostic Radiology | $200.00 |
| Stephen Kovacs | Erie, PA | Pulmonary Disease | $129.25 |
| Abid Khokar | Phoenix, AZ | Pulmonary Disease | $90.38 |
| Ali Saeed | Phoenix, AZ | Pulmonary Disease | $90.38 |
Prescribed Imbio Lung Density Analysis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.